Interim Scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L Value Sets

Value in Health - Tập 15 - Trang 708-715 - 2012
Ben van Hout1, M.F. Janssen2, You-Shan Feng3, Thomas Kohlmann3, Jan Busschbach4, Dominik Golicki5, Andrew Lloyd6, Luciana Scalone7,8, Paul Kind9, A. Simon Pickard10
1University of Sheffield, Sheffield, UK
2EuroQol Group, Rotterdam, The Netherlands
3Institute for Community Medicine, University of Greifswald, Greifswald, Germany
4Medical Psychology and Psychotherapy, Erasmus University, Rotterdam, Viersprong, Halsteren, The Netherlands
5Medical University of Warsaw, Warsaw, Poland
6Oxford Outcomes, Oxford, UK
7Research Centre on Public Health, University of Milano – Bicocca, Milan, Italy
8CHARTA Foundation, Milano, Milan, Italy
9Centre for Health Economics, University of York, York, UK
10Center for Pharmacoeconomic Research, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA

Tài liệu tham khảo

Rabin, 2001, EQ-5D: a measure of health status from the EuroQol Group, Ann Med, 33, 337, 10.3109/07853890109002087 Szende, 2007 Herdman, 2011, Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L), Qual Life Res, 20, 1727, 10.1007/s11136-011-9903-x Pickard, 2007, Health utilities using the EQ-5D in studies of cancer, Pharmacoeconomics, 25, 365, 10.2165/00019053-200725050-00002 Janssen, 2011, The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus, Diabet Med, 28, 395, 10.1111/j.1464-5491.2010.03136.x Pickard, 2008, Use of a preference-based measure of health (EQ-5D) in COPD and asthma, Respir Med, 102, 519, 10.1016/j.rmed.2007.11.016 Dyer, 2010, A review of health utilities using the EQ-5D in studies of cardiovascular disease, Health Qual Life Outcomes, 8, 1, 10.1186/1477-7525-8-13 Johnson, 2000, Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada, Med Care, 38, 115, 10.1097/00005650-200001000-00013 Johnson, 1998, Comparison of the EQ-5D and SF-12 in an adult US sample, Qual Life Res, 7, 155, 10.1023/A:1008809610703 Pickard, 2007, Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients, Med Care, 45, 259, 10.1097/01.mlr.0000254515.63841.81 Janssen, 2008, Comparing the standard EQ-5D three-level system with a five-level version, Value Health, 11, 275, 10.1111/j.1524-4733.2007.00230.x Pickard, 2007, Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients, Med Care, 45, 259, 10.1097/01.mlr.0000254515.63841.81 Janssen, 2008, Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods, Qual Life Res, 17, 463, 10.1007/s11136-008-9318-5 Mortimer, 2008, Comparing the incomparable?, Med Decis Making, 28, 66, 10.1177/0272989X07309642 Hays, 2000, Item response theory and health outcomes measurement in the 21st century, Med Care, 38, II28 Dolan, 1997, Modeling valuations for EuroQol health states, Med Care, 35, 1095, 10.1097/00005650-199711000-00002 Masters, 1982, A Rasch model for partial credit scoring, Psychometrika, 47, 149, 10.1007/BF02296272 Muraki, 1992, A generalized partial credit model: application of an EM algorithm, Appl Psychol Meas, 16, 159, 10.1177/014662169201600206 Pickard, 2007, Evaluating equivalency between response systems: application of the Rasch model to a 3-level and 5-level EQ-5D, Med Care, 45, 812, 10.1097/MLR.0b013e31805371aa Gray, 2006, Estimating the association between SF-12 responses and EQ-5D utility values by response mapping, Med Decis Making, 26, 18, 10.1177/0272989X05284108 Brazier, 2010, A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures, Eur J Health Econ, 11, 215, 10.1007/s10198-009-0168-z